Literature DB >> 24972311

Fusobacterium and Enterobacteriaceae: important players for CRC?

Emma Allen-Vercoe1, Christian Jobin2.   

Abstract

The gut microbiota plays an essential role in regulating intestinal homeostasis through its capacity to modulate various biological activities ranging from barrier, immunity and metabolic function. Not surprisingly, microbial dysbiosis is associated with numerous intestinal disorders including inflammatory bowel diseases (IBD) and colorectal cancer (CRC). In this piece, we will review recent evidence that gut microbial dysbiosis can influence intestinal disease, including colitis and CRC. We will discuss the biological events implicated in the development of microbial dysbiosis and the emergence of CRC-associated microorganisms, focusing on Escherichia coli and Fusobacterium nucleatum. Finally, the mechanisms by which E. coli and F. nucleatum exert potentially carcinogenic effects on the host will be reviewed.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Inflammation; Intestine; Microbiome

Mesh:

Year:  2014        PMID: 24972311      PMCID: PMC4259803          DOI: 10.1016/j.imlet.2014.05.014

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  96 in total

1.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.

Authors:  Yukihiro Furusawa; Yuuki Obata; Shinji Fukuda; Takaho A Endo; Gaku Nakato; Daisuke Takahashi; Yumiko Nakanishi; Chikako Uetake; Keiko Kato; Tamotsu Kato; Masumi Takahashi; Noriko N Fukuda; Shinnosuke Murakami; Eiji Miyauchi; Shingo Hino; Koji Atarashi; Satoshi Onawa; Yumiko Fujimura; Trevor Lockett; Julie M Clarke; David L Topping; Masaru Tomita; Shohei Hori; Osamu Ohara; Tatsuya Morita; Haruhiko Koseki; Jun Kikuchi; Kenya Honda; Koji Hase; Hiroshi Ohno
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

Review 2.  Do bacterial genotoxins contribute to chronic inflammation, genomic instability and tumor progression?

Authors:  Lina Guerra; Riccardo Guidi; Teresa Frisan
Journal:  FEBS J       Date:  2011-05-17       Impact factor: 5.542

Review 3.  Role of commensal gut bacteria in inflammatory bowel diseases.

Authors:  Gunnar Loh; Michael Blaut
Journal:  Gut Microbes       Date:  2012-10-11

4.  Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis.

Authors:  Aurélien Trompette; Eva S Gollwitzer; Koshika Yadava; Anke K Sichelstiel; Norbert Sprenger; Catherine Ngom-Bru; Carine Blanchard; Tobias Junt; Laurent P Nicod; Nicola L Harris; Benjamin J Marsland
Journal:  Nat Med       Date:  2014-01-05       Impact factor: 53.440

5.  Intestinal inflammation targets cancer-inducing activity of the microbiota.

Authors:  Janelle C Arthur; Ernesto Perez-Chanona; Marcus Mühlbauer; Sarah Tomkovich; Joshua M Uronis; Ting-Jia Fan; Barry J Campbell; Turki Abujamel; Belgin Dogan; Arlin B Rogers; Jonathan M Rhodes; Alain Stintzi; Kenneth W Simpson; Jonathan J Hansen; Temitope O Keku; Anthony A Fodor; Christian Jobin
Journal:  Science       Date:  2012-08-16       Impact factor: 47.728

6.  Update on the taxonomy and clinical aspects of the genus fusobacterium.

Authors:  Diane M Citron
Journal:  Clin Infect Dis       Date:  2002-09-01       Impact factor: 9.079

7.  Streptococcus cristatus attenuates Fusobacterium nucleatum-induced interleukin-8 expression in oral epithelial cells.

Authors:  G Zhang; R Chen; J D Rudney
Journal:  J Periodontal Res       Date:  2008-08       Impact factor: 4.419

8.  Genome sequence of Fusobacterium nucleatum subspecies polymorphum - a genetically tractable fusobacterium.

Authors:  Sandor E Karpathy; Xiang Qin; Jason Gioia; Huaiyang Jiang; Yamei Liu; Joseph F Petrosino; Shailaja Yerrapragada; George E Fox; Susan Kinder Haake; George M Weinstock; Sarah K Highlander
Journal:  PLoS One       Date:  2007-08-01       Impact factor: 3.240

9.  Interplay between siderophores and colibactin genotoxin biosynthetic pathways in Escherichia coli.

Authors:  Patricia Martin; Ingrid Marcq; Giuseppe Magistro; Marie Penary; Christophe Garcie; Delphine Payros; Michèle Boury; Maïwenn Olier; Jean-Philippe Nougayrède; Marc Audebert; Christian Chalut; Sören Schubert; Eric Oswald
Journal:  PLoS Pathog       Date:  2013-07-11       Impact factor: 6.823

10.  Paneth cells as a site of origin for intestinal inflammation.

Authors:  Timon E Adolph; Michal F Tomczak; Lukas Niederreiter; Hyun-Jeong Ko; Janne Böck; Eduardo Martinez-Naves; Jonathan N Glickman; Markus Tschurtschenthaler; John Hartwig; Shuhei Hosomi; Magdalena B Flak; Jennifer L Cusick; Kenji Kohno; Takao Iwawaki; Susanne Billmann-Born; Tim Raine; Richa Bharti; Ralph Lucius; Mi-Na Kweon; Stefan J Marciniak; Augustine Choi; Susan J Hagen; Stefan Schreiber; Philip Rosenstiel; Arthur Kaser; Richard S Blumberg
Journal:  Nature       Date:  2013-10-02       Impact factor: 49.962

View more
  50 in total

Review 1.  Microbiota and host immune responses: a love-hate relationship.

Authors:  Sarah Tomkovich; Christian Jobin
Journal:  Immunology       Date:  2015-11-02       Impact factor: 7.397

Review 2.  Collateral damage: insights into bacterial mechanisms that predispose host cells to cancer.

Authors:  Aurélie Gagnaire; Bertrand Nadel; Didier Raoult; Jacques Neefjes; Jean-Pierre Gorvel
Journal:  Nat Rev Microbiol       Date:  2017-01-03       Impact factor: 60.633

3.  Prelude to oral microbes and chronic diseases: past, present and future.

Authors:  Kalina R Atanasova; Özlem Yilmaz
Journal:  Microbes Infect       Date:  2015-03-24       Impact factor: 2.700

4.  Fusobacterium nucleatum infections: clinical spectrum and bacteriological features of 78 cases.

Authors:  E Denes; O Barraud
Journal:  Infection       Date:  2016-01-18       Impact factor: 3.553

Review 5.  The gut microbiome and colorectal cancer: a review of bacterial pathogenesis.

Authors:  Jessica D Dahmus; Drew L Kotler; David M Kastenberg; C Andrew Kistler
Journal:  J Gastrointest Oncol       Date:  2018-08

Review 6.  How the evolving epidemics of opioid misuse and HIV infection may be changing the risk of oral sexually transmitted infection risk through microbiome modulation.

Authors:  Wiley D Jenkins; Lauren B Beach; Christofer Rodriguez; Lesli Choat
Journal:  Crit Rev Microbiol       Date:  2020-01-30       Impact factor: 7.624

Review 7.  Carcinogenesis and therapeutics: the microbiota perspective.

Authors:  Matthew C B Tsilimigras; Anthony Fodor; Christian Jobin
Journal:  Nat Microbiol       Date:  2017-02-22       Impact factor: 17.745

8.  Rectal microbiota among HIV-uninfected, untreated HIV, and treated HIV-infected in Nigeria.

Authors:  Rebecca G Nowak; Søren M Bentzen; Jacques Ravel; Trevor A Crowell; Wuese Dauda; Bing Ma; Hongjie Liu; William A Blattner; Stefan D Baral; Manhattan E Charurat
Journal:  AIDS       Date:  2017-03-27       Impact factor: 4.177

9.  Visceral hypersensitive rats share common dysbiosis features with irritable bowel syndrome patients.

Authors:  Xiao-Yan Zhou; Ming Li; Xia Li; Xin Long; Xiu-Li Zuo; Xiao-Hua Hou; Ying-Zi Cong; Yan-Qing Li
Journal:  World J Gastroenterol       Date:  2016-06-14       Impact factor: 5.742

10.  Association of Fusobacterium nucleatum infection with colorectal cancer in Chinese patients.

Authors:  Yu-Yuan Li; Quan-Xing Ge; Jie Cao; Yong-Jian Zhou; Yan-Lei Du; Bo Shen; Yu-Jui Yvonne Wan; Yu-Qiang Nie
Journal:  World J Gastroenterol       Date:  2016-03-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.